Health Populi

OCTOBER 28, 2019

patients’ negative views of the pharmaceutical industry in this study was the opioid epidemic. Over one-half of Americans blame pharmaceutical companies as most responsible for the opioid crisis, followed by physicians, whom 39% of health consumers blame, and patients, whom 38% of people blame. Exacerbating U.S.

Pharmaceuticals 136

Pharmaceuticals Medical Billing Medicare Mental health 136

Health Populi

JANUARY 5, 2021

When he led Turing Pharmaceuticals in 2015, he acquired a license for the drug Daraprim (an anti-malarial therapy also used for HIV/AIDS), raising the drug price from $13.50 Among the ten awards, I’ve selected three to highlight to synthesize one systemic issue that has plagued America’s response to the public health crisis.

Public Health 156

Public Health Pharmaceuticals Leadership Life Science 156

Health Populi

MARCH 22, 2022

Health Populi’s Hot Points: The concept of financial toxicity was raised in a 2014 60 Minutes segment during which correspondent Lesley Stahl spoke with Dr. Leonard Saltz of Memorial Sloan Kettering Medical Center in New York City. Dr. Saltz was speaking as chief of the department of gastrointestinal oncology.

Medical Billing 170

Medical Billing Pharmaceuticals Health Policy 170

Health Populi

JUNE 7, 2018

Some key findings from this study were that: The fastest-growing spending conditions between 2013 and 2014 were infectious disease, mental illness, and diabetes. The second chart indicates healthcare spending by category in billions of dollars and annual rate of growth.

Pharmaceuticals 206

Pharmaceuticals Public Health Mental health Health Policy 206

Health Populi

MAY 8, 2019

Total patient OOP costs in 2018 reached $61 billion, up $2 bn from 2017, and $5 bn from 2014. Just under 9% of patients across all three health plan types had over $500 in OOP costs in 2018. This takes us from the pharma manufacturer’s perspective to the patient’s role in the Rx ecosystem.

Medicare 149

Medicare BioTech Pharmaceuticals Mental health 149

Henry Kotula

JULY 1, 2019

Thirty-eight percent of large employers offered a worksite clinic in 2019, up from 27 percent in 2014. The trend has implications for employers, payers, providers and even pharmaceutical and life science companies. WHAT ELSE YOU SHOULD KNOW.

Life Science 32

Life Science Pharmaceuticals Mental health Telemedicine 32